REFRACT - Refractory lupus nephritis: a tissue-based pathophysiological approach performed within the frame of a clinical trial designed to test the efficacy of rituximab

Objectives of the Project

Lupus nephritis (LN) remains a severe complication of SLE. Several studies have demonstrated that an absence of early response to therapy is a poor long-term renal prognostic factor and special care should be given to these patients.

Read more

Facts and Figures

Project Lead
Prof. F. Houssiau
Cliniques Universitaire Saint-Luc, Université catholique de Louvain
FOREUM research grant: € 298.860
May 2016, Duration 3 years

Meet the Team

Prof. F. Houssiau
Cliniques Universitaire Saint-Luc, Université catholique de Louvain
Prof. M. Mahévas
Université Paris-Descartes
Prof. R. van Vollehoven
Karolinska Institutet
Prof. D. Jayne
Adensbrooke's Hospital, University of Cambridge
Prof. R. Cervera
Fundacio Clinic per a la Recerca Biomedica Barcelona
Dr. P. Remy
Université Paris-Est

Patient Voice

We have involved Lupus Europe in the process as a patient partner organisation.